Patents by Inventor Jesse Lyons

Jesse Lyons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T cells surface-loaded with immunostimulatory fusion molecules and uses thereof
    Patent number: 11471490
    Abstract: Immunostimulatory fusion molecules that include an immune cell targeting moiety and a cytokine molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: October 18, 2022
    Assignee: Torque Therapeutics, Inc.
    Inventors: Thomas L. Andresen, De-Kuan Chang, Douglas S. Jones, Jesse Lyons, Jonathan D. Nardozzi, Ulrik B. Nielsen, Michael Feldhaus
  • Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof
    Publication number: 20210017247
    Abstract: Fusion proteins that include an immune (e.g., Treg) targeting moiety and a cytokine or growth factor molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.
    Type: Application
    Filed: July 3, 2018
    Publication date: January 21, 2021
    Inventors: Douglas S. Jones, Jesse Lyons, Ulrik B. Nielsen
  • Immunostimulatory Fusion Molecules and Uses Thereof
    Publication number: 20200330514
    Abstract: Immunostimulatory fusion molecules that include an immune cell targeting moiety and a cytokine molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.
    Type: Application
    Filed: July 3, 2018
    Publication date: October 22, 2020
    Inventors: Thomas L. Andresen, De-Kuan Chang, Douglas S. Jones, Jesse Lyons, Jonathan D. Nardozzi, Ulrik B. Nielsen